Make room in your agenda and join these interesting industry session! All sessions are happening in the Theatre in Hall 11.
Industry Sessions
Industry Sessions
| Wednesday, 26 October 2022 | ||
| 11:05 – 11:25 | Product Theatre – Precision Medicine: From Research to Clinical Practice Speaker: Jim Eubanks (Minneapolis, US), Stephen Krieger (New York City, US), Jennifer Graves (San Diego, US), Barry Singer (St. Louis, US), Tanuja Chitnis (Massachusetts, US) |
supported by  |
| 12:45 – 13:05 | Product Theatre – Changing Perspective on Drivers of Disability Accumulation: The Role of Neuroinflammation Speaker: Celia Oreja-Guevara (Madrid, ES) |
supported by  |
| 14:00 – 14:20 | Product Theatre – PONVORY® (ponesimod) at first-line: focus on efficacy outcomes in relapsing multiple sclerosis with active disease Speaker: Giancarlo Comi (Milan, IT) & Philipp Albrecht (Düsseldorf, DE) |
supported by  |
| 16:10 – 16:40 | Brain Exchange – Improving MS Clinical Outcomes: The Emerging Role of Remote Sensor-Based Digital Assessments Speaker: Licinio Craveiro (Basel, CH) & Robert K Shin (Washington DC, US) |
supported by  |
| 17:00 – 17:30 | Brain Exchange – Debunking Common Myths of MS Speaker: Hans-Peter Hartung (Düsseldorf, DE) & Diego Silva (New Jersey, US) |
supported by  |
| Thursday, 27 October 2022 | ||
| 09:30 – 09:50 | Product Theatre – The Need for Brain-Penetrance and Bioactivity in Next Generation Treatments Speaker: Celia Oreja-Guevara (Madrid, ES) |
supported by |
| 11:05 – 11:25 | Product Theatre – Early use of TYSABRI (natalizumab) in the treatment paradigm of patients with relapsing forms of multiple sclerosis Speaker: Celia Oreja-Guevara (Madrid, ES) |
supported by  |
| 13:10 – 13:40 | Brain Exchange – Increasing Diversity in MS Clinical Trials Speaker: Mitzi Williams (Atlanta, US), Gavin Giovannoni (London, US) & Alexandra Goodyear (South San Francisco, US) |
supported by |
| 14:40 – 15:00 | Product Theatre – Early Experience With MAVENCLAD® Speaker: Ravi Dukkipati (Pennsylvania, US) |
supported by  |
| 16:40 – 17:10 | Brain Exchange – Pursuing precision: Imaging and biomarkers in NMOSD Speaker: Maciej Juryńczyk (Warsaw, PL), Jens Wuerfel (Basel, CH) & Patrick Waters (Oxford, UK) |
supported by |
| 17:20 – 17:40 | Product Theatre – Clinical Implications of COVID Immunization for MS patients Speaker: Heinz Wiendl (Münster, DE) & Maria Pia Sormani (Genoa, IT) |
supported by |
| 17:50 – 18:20 | Brain Exchange – The case for therapeutic drug monitoring of biologic therapies used in Multiple Sclerosis Speaker: John Foley (Salt Lake City, US) & Bradley Messmer (Lund, SE) |
supported by  |
| Friday, 28 October 2022 | ||
| 09:30 – 10:00 | Brain Exchange – Digital Health Technology and the Impact on MS Care Speaker: Stanley Cohan (Oregon, US), Robert Shin (Washington DC, US) & Klaus Schmierer (London, UK) |
supported by  |
| 11:40 – 12:00 | Product Theatre – Experience with VUMERITY (diroximel fumarate): Evidence from clinical trials and use in clinical practice Speaker: Sibyl Wray (Knoxville, US), Daniel Bandari (Laguna Hills, US) |
supported by |
| 13:40 – 14:00 | Product Theatre – A Deep Dive on how Microglia May Drive Disease Pathology Behind the BBB Speaker: Celia Oreja-Guevara (Madrid, ES) |
supported by |